References
- Neumann PJ, Stone PW, Chapman RII, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976–1997. Ann. Intern. Med. 132(12), 964–972 (2000).
- Sculpher M, Gafni A. Recognizing diversity in public preferences: the use of preference subgroups in cost-effectiveness analysis. Health Econ. 10(4), 317–324 (2001).
- Bala MV, Zarkin GA. Pharmacogenomics and the evolution of healthcare: is it time for cost-effectiveness analysis at the individual level? PharmacoEconomics22 (8), 495–498 (2004).
- Coyle D, Buxton MJ, O'Brien BJ. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 12(5), 421–427 (2003).